Abstract
The Indo–Swiss symposium on advances in pharmacogenomic strategies for implementation of personalized medicine was conducted as a part of the JIPMER Integrated Pharmacogenomics Program (JIPP), held in Puducherry, India on 23 November 2019. The symposium focused on the growing contribution of pharmacogenomic information in designing treatment strategies and promoting better approaches to personalized medicine. The primary objective of this symposium was to bridge gaps in understanding the basics and recent advances in the field of pharmacogenomics. This symposium sought to promote interaction between the Indian and Swiss researchers to initiate future collaborative research projects. This symposium also served as a platform for young researchers to present their research findings as posters to the audience.
Author contributions
All authors were involved in conducting the conference. Material preparation was done by S Xaviar. The first draft of the manuscript was written by S Xaviar and further revised by S Kumar and Uppugunduri S Chakaradhara Rao. All authors revised the previous versions of the manuscript. All authors read and approved the final manuscript.
Acknowledgments
The authors would like to acknowledge the efforts of each and every one from the Department of Pharmacology, JIPMER along with swissnex, India and Research platform for Paediatric Onco-Haematology (Department of Paediatrics, Gynaecology and Obstetrics, University of Geneva), Clinical Pharmacology Division, Geneva University Hospitals, and ZHAW, Switzerland without which this symposium wouldn’t have been materialized into such a positive and vibrant learning experience. The authors would also like to thank all the participants, chairs and speakers for their enthusiastic and wholehearted participation.
Financial & competing interests disclosure
This symposium received funding from Medical Council of India (MCI), Swissnex India, CANSEARCH Foundation and ZHAW, Switzerland. The authors thank Medical council of India (MCI) for helping with the funding of our program. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
List of speakers and chairs (in the order of the program schedule)
R Aggarwal is the Director of Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. R Raveendran is Professor and Head, Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Urs A Meyer is the Professor of Pharmacology, University of Basel, Switzerland. A Hamide, Professor of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. M George is the Associate professor, Department of Clinical Pharmacology, Sri Ramachandra Medical College Hospital and Research Centre, Chennai, India. S Satheesh is the Professor of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. R Venkatasan is the Executive Scientific Officer and Head of Molecular Genetics, Madras Diabetes Research Foundation, Chennai, India. M Wyawahare is the Additional Professor of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. J Sahoo is the Associate Professor of endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. M Tripathi is the Professor of Neurology, All India Institute of Medical Sciences, New Delhi, India. PP Nair is the Head of Department, Neurology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. R Kesavan is the Associate Professor, Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. RP Rajkumar is the Additional Professor, Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. DKS Subrahmanyam is the Professor and Head, Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. S Kayal is the Additional Professor, Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Biswajit D is the Additional Professor, Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Jayanthi M is the Additional Professor, Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Marc Ansari is the Associate Professor, Faculty of Medicine, University of Geneva, Switzerland. P Ganesan is the Additional professor, Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Youssef Daali is the Assistant professor, University of Geneva, Switzerland. B Chanaveerappa is the Additional Professor of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. S Sandhiya is the Associate Professor, Clinical Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Uppugunduri S Chakradhara Rao is the Head of Experimental Research, Research Platform for Paediatric Onco-Haematology, University of Geneva, Switzerland. C Adithan is the Dean-Research, Sri Balaji Vidyapeeth University, Puducherry, India. T Kumarasamy is the Senior scientist, Center for Cellular and Molecular Biology, Hyderabad, India. A Kumaraswamy, Swissnex India, Bangalore, India.